|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017601,
umls-concept:C0028840,
umls-concept:C0030705,
umls-concept:C0033085,
umls-concept:C0036043,
umls-concept:C0439185,
umls-concept:C0441889,
umls-concept:C0851347,
umls-concept:C0936012,
umls-concept:C1274040,
umls-concept:C1451502
|
|
pubmed:dateCreated |
2008-8-28
|
|
pubmed:abstractText |
Tafluprost is a new prostaglandin F(2alpha) (PGF(2alpha)) derivative in development for the treatment of glaucoma. Tafluprost is the first PGF(2alpha) analogue with a preservative-free formulation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1755-3776
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
242
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
14-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18752510-Adult,
pubmed-meshheading:18752510-Aged,
pubmed-meshheading:18752510-Aged, 80 and over,
pubmed-meshheading:18752510-Antihypertensive Agents,
pubmed-meshheading:18752510-Cross-Over Studies,
pubmed-meshheading:18752510-Double-Blind Method,
pubmed-meshheading:18752510-Female,
pubmed-meshheading:18752510-Glaucoma, Open-Angle,
pubmed-meshheading:18752510-Humans,
pubmed-meshheading:18752510-Intraocular Pressure,
pubmed-meshheading:18752510-Male,
pubmed-meshheading:18752510-Middle Aged,
pubmed-meshheading:18752510-Ocular Hypertension,
pubmed-meshheading:18752510-Preservatives, Pharmaceutical,
pubmed-meshheading:18752510-Prostaglandins F,
pubmed-meshheading:18752510-Therapeutic Equivalency,
pubmed-meshheading:18752510-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis.
|
|
pubmed:affiliation |
Augenzentrum Dr. Hamacher Praxis, Maximilianstrasse 2B, Starnberg, Germany. praxis@augenzentrum-dr-hamacher.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|
